BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25320942)

  • 1. [Mesalazine-related interstitial lung disease: an under-diagnosed effect?].
    Auffret M; Béné J; Lambert M; Gautier S
    Therapie; 2014; 69(6):531-2. PubMed ID: 25320942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial pneumonia related to mesalamine].
    Lamsiah T; Moudden K; Baaj M; Hadri L
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
    Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
    Tsuboi R; Matsumoto S; Miyatani H; Mashima H
    Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
    Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ
    Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
    Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
    Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 10. Nongranulomatous interstitial lung disease in Crohn's disease.
    Hotermans G; Benard A; Guenanen H; Demarcq-Delerue G; Malart T; Wallaert B
    Eur Respir J; 1996 Feb; 9(2):380-2. PubMed ID: 8777981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic interstitial nephritis and mesalazine: 3 new cases?].
    Brouillard M; Gheerbrant JD; Gheysens Y; Fleury D; Devred M; Hazzan M; Colombel JF
    Gastroenterol Clin Biol; 1998; 22(8-9):724-6. PubMed ID: 9823562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].
    Shimizu T; Hayashi M; Shimizu N; Kinebuchi S; Toyama J
    Nihon Kokyuki Gakkai Zasshi; 2009 Jun; 47(6):543-7. PubMed ID: 19601534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
    Schwörer H; Ramadori G
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1328-30. PubMed ID: 11109415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Colombel JF; Lémann M; Cassagnou M; Bouhnik Y; Duclos B; Dupas JL; Notteghem B; Mary JY
    Am J Gastroenterol; 1999 Mar; 94(3):674-8. PubMed ID: 10086650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalazine-induced lupus.
    Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
    Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.
    Foster RA; Zander DS; Mergo PJ; Valentine JF
    Inflamm Bowel Dis; 2003 Sep; 9(5):308-15. PubMed ID: 14555914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine-induced lung fibrosis.
    Alskaf E; Aljoudeh A; Edenborough F
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe myalgia associated with mesalazine treatment in a child with Crohn's disease.
    Persić M; Palcevski G; Slavić I; Vlahović-Palcevski V
    Eur J Clin Pharmacol; 2007 Mar; 63(3):315-7. PubMed ID: 17242922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
    Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
    Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.